TOI - Oncology Institute Inc (The)
IEX Last Trade
0.3612
-0.020 -5.648%
Share volume: 123,037
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
PREVIOUS CLOSE
CHG
CHG%
$0.38
-0.02
-5.35%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-10 | 2022-08-09 | 2022-11-09 | 2023-03-16 | 2023-05-10 | 2023-08-09 | 2023-11-08 | 2024-03-28 | |
| Total revenue | 55.161 M | 60.921 M | 64.977 M | 71.424 M | 76.192 M | 80.224 M | 82.035 M | 85.788 M | |
| Cost of revenue | 42.839 M | 49.779 M | 51.977 M | 55.795 M | 62.093 M | 65.107 M | 66.057 M | 71.409 M | |
| Gross profit | 12.322 M | 11.142 M | 13.000 M | 15.629 M | 14.099 M | 15.117 M | 15.978 M | 14.379 M | |
| -9.58% | 16.68% | 20.22% | -9.79% | 7.22% | 5.70% | -10.01% | |||
| Operating expenses | 29.806 M | 28.348 M | 31.963 M | 29.572 M | 28.830 M | 28.726 M | 28.205 M | 28.090 M | |
| Selling general and admin | 29.806 M | 28.348 M | 31.963 M | 29.572 M | 28.830 M | 28.726 M | 28.205 M | 28.090 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 73.632 M | 79.225 M | 85.074 M | 86.559 M | 92.192 M | 95.162 M | 95.960 M | 101.076 M | |
| 7.60% | 7.38% | 1.75% | 6.51% | 3.22% | 0.84% | 5.33% | |||
| Operating income | -18.471 M | -18.304 M | -20.097 M | -15.135 M | -16.000 M | -14.938 M | -13.925 M | -15.288 M | |
| Ebit | -18.471 M | -18.304 M | -20.097 M | -15.135 M | -16.000 M | -14.938 M | -13.925 M | -15.288 M | |
| Pretax income | 19.466 M | -5.485 M | -2.698 M | -11.374 M | -29.954 M | -16.798 M | -17.284 M | -19.068 M | |
| -128.18% | -50.81% | 321.57% | 163.36% | -43.92% | 2.89% | 10.32% | |||
| Income tax | 180.000 K | -32.000 K | -24.000 K | -367.000 K | 44.000 K | 99.000 K | 135.000 K | -314.000 K | |
| Net income basic | 19.286 M | -5.453 M | -2.674 M | -11.007 M | -29.998 M | -16.897 M | -17.419 M | -18.754 M | |
| -128.27% | 50.96% | -311.63% | -172.54% | 43.67% | -3.09% | -7.66% | |||
| Net income | 19.286 M | -5.453 M | -2.674 M | -11.007 M | -29.998 M | -16.897 M | -17.419 M | -18.754 M | |
| -128.27% | 50.96% | -311.63% | -172.54% | 43.67% | -3.09% | -7.66% |